PAL-4

CAS No. 2609594-35-4

PAL-4( 1H-1,2,4-Triazol-5-amine, 3-[[(4-chlorophenyl)methyl]thio]-1-[(2,3-dihydro-5-benzofuranyl)sulfonyl]- )

Catalog No. M28869 CAS No. 2609594-35-4

PAL-4 stimulates the activity of LYPLAL1, a poorly characterized serine hydrolase with complex genetic links to human metabolic traits.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 215 In Stock
5MG 192 In Stock
10MG 283 In Stock
25MG 452 In Stock
50MG 631 In Stock
100MG 848 In Stock
200MG 1107 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PAL-4
  • Note
    Research use only, not for human use.
  • Brief Description
    PAL-4 stimulates the activity of LYPLAL1, a poorly characterized serine hydrolase with complex genetic links to human metabolic traits.
  • Description
    PAL-4 stimulates the activity of LYPLAL1, a poorly characterized serine hydrolase with complex genetic links to human metabolic traits.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    1H-1,2,4-Triazol-5-amine, 3-[[(4-chlorophenyl)methyl]thio]-1-[(2,3-dihydro-5-benzofuranyl)sulfonyl]-
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    glucocerebrosidase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2609594-35-4
  • Formula Weight
    422.91
  • Molecular Formula
    C17H15ClN4O3S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Nc1nc(SCc(cc2)ccc2Cl)nn1S(c(cc1)cc2c1OCC2)(=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Marugan JJ, et al. Evaluation of quinazoline analogues as glucocerebrosidase inhibitors with chaperone activity. J Med Chem. 2011 Feb 24;54(4):1033-58.
molnova catalog
related products
  • PAR-3 (1-6) (human)

    PAR3 (1-6) is a synthetic peptide agonist of proteinase-activated receptor 1 (PAR1) that corresponds to residues 1-6 of the amino terminal tethered ligand sequence of human PAR3 and residues 39-44 of the full-length human sequence. PAR3 (1-6) activates p42/44 MAPK signaling in fibroblasts expressing PAR1, but not PAR3, an effect that can be blocked by the PAR1 antagonist RWJ 56110.

  • cucurbitacin E-2-O-β...

    Colocynthin is a cucurbitane triterpenoid glycoside that can be isolated from the bitter apple (Citrullus colocynthis).

  • Murlentamab

    Murlentamab (GM102) is a humanized anti-AMhRII antibody.